论文部分内容阅读
目的:分析血塞通注射液与络活喜片联合治疗高血压的临床疗效。方法:收集我院2012年11月—2013年11月期间诊治的高血压患者80例作为研究对象,随机分为观察组与对照组,每组患者各40例。对照组患者单纯采用络活喜片治疗,观察组患者采用血塞通注射液与络活喜片联合治疗,对两组患者的整体治疗效果、治疗前后血压水平及症状积分进行分析对比。结果:研究结果显示,观察组中有30例(75.0%)显效,7例(17.5%)有效,总有效率为92.5%;对照组中有18例(45.0%)显效,9例(22.5%)有效,总有效率为67.5%,观察组患者的治疗效果明显优于对照组(P<0.05)。两组患者治疗前血压水平和症状积分比较无明显差异(P>0.05),经治疗后均得到明显改善(P<0.05),且观察组改善水平明显优于对照组(P<0.05)。结论:血塞通注射液与络活喜片联合治疗高血压病具有良好的临床疗效,能有效提高治疗效果,促进症状和血压水平改善,值得在临床应用中推广。
Objective: To analyze the clinical effect of Xuesaitong injection and Luohuo tablets in the treatment of hypertension. Methods: Totally 80 hypertensive patients diagnosed and treated in our hospital from November 2012 to November 2013 were randomly divided into observation group and control group, 40 cases in each group. The patients in the control group were treated with Fuhuoxi tablets only. The patients in the observation group were treated with Xuesaitong injection and Fuhuoxi tablets. The overall treatment effect, blood pressure and symptom scores before and after treatment were compared and analyzed. Results: The results showed that in the observation group, 30 cases (75.0%) were effective, 7 cases (17.5%) were effective, the total effective rate was 92.5%; 18 cases (45.0% ), The total effective rate was 67.5%. The treatment effect of the observation group was obviously better than that of the control group (P <0.05). There was no significant difference in the blood pressure and symptom score between the two groups before treatment (P> 0.05), and after treatment, they were significantly improved (P <0.05). The improvement in the observation group was significantly better than that in the control group (P <0.05). Conclusion: The combination of Xuesaitong injection and Fuhuoxi tablets has good clinical curative effect on hypertension, which can effectively improve the therapeutic effect, promote the improvement of symptoms and blood pressure level, and is worth popularizing in clinical application.